You are here
Home > Healthcare > Shares Information Report on Great Basin Scientific, Inc. (NASDAQ:GBSN)

Shares Information Report on Great Basin Scientific, Inc. (NASDAQ:GBSN)

On Wednesday, Great Basin Scientific, Inc. (NASDAQ:GBSN) opened its trade at $0.18. The stock after floating in a range of $0.16 - 0.18, settled at $0.16. The stock’s 52-week range is $0.11 - 366.00. The stock exchanged hands with 13,816,904 shares compared to its average daily volume of 13,004,300 shares. The stock holds market capitalization of $18.53M.

Key Earnings Data:

Great Basin Scientific, Inc. (NASDAQ:GBSN)’s current quarter estimate is N/A. Current year estimate is N/A. Most accurate estimate is N/A. Zacks Expected Surprise Prediction for this stock is 0.00%. The next expected earnings date is 5/12/16. Prior year earnings per share was $-20.81. Last quarter earnings per share was $-11.38. Last earnings per share surprise were up 5.26%.

In past 4 weeks the stock price changes -2.25%. For three months, the price changes -78.77%. Further year to date it changes -78.72%

Similarly if we seek Price Change Relative to S&P 500, then one come to know that

In past 4 weeks the stock price changes -7.28%. For three months, the price changes -79.02%. Further year to date it changes -78.64%

Looking into share information of the stock, there are 114.23M shares outstanding. Last split date of the stock is 12/14/2015.

On December 11, 2015, Great Basin Scientific, Inc. (NASDAQ:GBSN), a molecular diagnostics company, declared that a 1-for-60 reverse split of its common stock will be effective at 5:00 pm EST on December 11, 2015. The Company’s common stock will open for trading on the NASDAQ Capital Market on Monday, December 14, 2015 on a post-split basis. At the effective time of the reverse stock split, every 60 shares of the Company’s issued and outstanding common stock, par value $0.001, will be merged into 1 newly issued and outstanding share of common stock, par value of $0.0001.

The reverse stock split will reduce the number of shares of the Company’s outstanding common stock from about 190.7 million to about 3.2 million. Proportional adjustments will be made to the Company’s outstanding preferred shares, unit purchase options, stock options, warrants, and equity incentive plan. The number of authorized shares of the Company’s common stock will remain unchanged.

FacebookTwitter
Tags :
Top